---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-302288"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2022-12-12T23:59:59+00:00"
generated_at: "2026-06-21T06:17:05.557272+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma increases authorized common shares from 40M to 160M

## Summary
- Stockholders approved amendment at Dec 7, 2022 annual meeting; effective Dec 9, 2022.
- Authorized common shares increased from 40,000,000 to 160,000,000.
- Certificate of Amendment filed with Delaware Secretary of State on Dec 9, 2022.

## SEC filing metadata
- accession: 0001193125-22-302288
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2022-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/0001193125-22-302288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/d429664d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-302288
- JSON: https://secwatch.observer/filing/0001193125-22-302288.json
- Plain text: https://secwatch.observer/filing/0001193125-22-302288.txt

## Key facts
- Governance Changes
  Benitec Biopharma Inc.: Increased authorized shares of common stock from 40,000,000 to 160,000,000 (effective 2022-12-09).
  - Change: charter amendment
  - Effective: 2022-12-09
  source text: the stockholders of the Company approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock of the Company from 40,000,000 to 160,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/0001193125-22-302288-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.